Abstract
Pars planitis is a diagnostic term that defines a subset of idiopathic intermediate uveitis where there is snowbank or snowball formation in the absence of infectious or systemic disease. It predominantly affects children and adolescents. Most cases are bilateral, with more severe disease seen in those with earlier onset. Most pediatric cases are relatively asymptomatic and found on routine examination. Testing should include ruling out both infectious and non-infectious etiologies of intermediate uveitis. Systemic associations are rarely seen in children. Treatment ranges from local medical therapy to systemic immunomodulation and surgical interventions for both control of the inflammation as well as repair of complications seen with pars planitis. Complications include cataract, macular edema, retinal neovascularization, vitreous hemorrhage, and retinal detachment. Adequate control of inflammation and prompt detection of associated complications are essential in improving the overall prognosis of the pediatric uveitis patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16.
Kump LI, et al. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112(7):1287–92.
Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259–69.
Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144:812–7.
Nikkhah H, Ramezani A, Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, et al. Childhood pars planitis; clinical features and outcomes. J Ophthalmic Vis Res. 2011;6:249–54.
Thorne JE, Daniel A, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am Ophthalmol. 2008;145:841–6.
Soylu M, Ozdemir G, Anli A. Pediatric uveitis in Southern Turkey. Ocul Immunol Inflamm. 1997;5:197–202.
Smith JA, Mackensen F, Sen HN, Leigh JF, Watkins AS, Pyatetsky D, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544–51.
Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299–306.
Paroli MP, Spinucci G, Monte R, Pesci FR, Abicca I, Pivetti PP. Intermediate uveitis in a pediatric Italian population. Ocul Immunol Inflamm. 2011;19:321–6.
Romero R, Peralta J, Sendagorta E, Abelairas J. Pars planitis in children: epidemiologic, clinical, and therapeutic characteristics. J Pediatr Ophthalmol Strabismus. 2007;44:288–93.
Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999;106:594–9.
Arellanes-GarcÃa L, Navarro-López P, Concha-Del RÃo LE, Unzueta-Medina JA. Idiopathic intermediate uveitis in childhood. Int Ophthalmol Clin. 2008;48:61–74.
Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. 1997;123:70–5.
de Boer J, Berendschot TT, van der Does P, Rothova A. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006;141:616–21.
Lauer AK, Smith JR, Robertson JE, Rosenbaum JT. Vitreous hemorrhage is a common complication of pediatric pars planitis. Ophthalmology. 2002;109:95–8.
Brockhurst RJ, Schepens CL. Peripheral uveitis. The complication of retinal detachment. Arch Ophthalmol. 1968;80: 747.
Deane JS, Rosenthal AR. Course and complications of intermediate uveitis. Acta Ophthalmol Scand. 1997;75:82–4.
Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003;135:867–78.
Tugal-Tutkun I, Ayranci O, Kasapcopur O, Kir N. Retrospective analysis of children with uveitis treated with infliximab. J AAPOS. 2008;12:611–3.
Ardoin SP, Kredich D, Rabinovich E, Schanberg LE, Jaffe GJ. Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. Am J Ophthalmol. 2007;144:844–9.
Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007;91:319–24.
Gallagher M, Quinones K, Cervantes-Castañeda RA, Yilmaz T, Foster CS. Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. 2007;91:1341–4.
Simonini G, Taddio A, Cattalini M, Caputo R, De Libero C, Naviglio S, et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res (Hoboken). 2011;63:612–8.
Simonini G, Taddio A, Cattalini M, Caputo R, de Libero C, Parentin F, et al. Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. Pediatr Rheumatol Online J. 2013;11:16.
Deuter CM, Kötter I, Günaydin I, Stübiger N, Doycheva DG, Zierhut M. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93:906–13.
Aaberg TM, Cesarz TJ, Flickinger RR. Jr Treatment of pars planitis I. Cryotherapy. Surv Ophthalmol. 1977;22:120–5.
Devenyi RG, Mieler WF, Lambrou FH, Will BR, Aaberg TM. Cryopexy of the vitreous base in the management of peripheral uveitis. Am J Ophthalmol. 1988;106:135–8.
Mieler WF, Aaberg TM. Further observations on cryotherapy of the vitreous base in the management of peripheral uveitis. Dev Ophthalmol. 1992;23:190–5.
Park SE, Mieler WF, Pulido JS. Peripheral scatter photocoagulation for neovascularization associated with pars planitis. Arch Ophthalmol. 1995;113:1277–80.
Pulido JS, Mieler WF, Walton D, Kuhn E, Postel E, Hartz A, et al. Results of peripheral laser photocoagulation in pars planitis. Trans Am Ophthalmol Soc. 1998;96:127–37.
Heiligenhaus A, Bornfeld N, Foerster MH, Wessing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol. 1994;78:549–54.
Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko E, Foster CS. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Ocul Immunol Inflamm. 2010;18:411–7.
Trittibach P, Koerner F, Sarra GM, Garweg JG. Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome. Eye (Lond). 2006;20:184–90.
Stavrou P, Baltatzis S, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm. 2001;9:141–51.
Ganesh SK, Babu K, Biswas J. Phacoemulsification with intraocular lens implantation in cases of pars planitis. J Cataract Refract Surg. 2004;30:2072–6.
Kaufman AH, Foster CS. Cataract extraction in patients with pars planitis. Ophthalmology. 1993;100:1210–7.
Capone A, T.M.A., Intermediate uveitis. In: Albert DM, Jakobiec FA. Editors. Principles and practice of ophthalmology. Philadelphia: WB Saunders Company;1994. p. 423–2.
Michelson JB, Friedlaender MH, Nozik RA. Lens implant surgery in pars planitis. Ophthalmology. 1990;97(8):1023–6.
Wiechens B, Nolle B, Reichelt JA. Pars plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239(7):474–81.
Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999;106:1086–90.
Kump L, Vitale AT, Foster CS. Pediatric uveitis. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. New Delhi, India: Highlights Medical Publishers; 2013. p. 1223–5.
Tugal-Tutkun I, Güney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol. 2009;148:510-5.e1.
Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm. 2004;12:7–16.
Forrester JV, Okada AA, Ben Ezra D, Ohno S, editors. Posterior segment intraocular inflammation: guidelines. The Hague, Netherlands: Kugler Publications;1998. Pars planitis. p. 93–7.
Malalis JF, Bhat P, Shaprio M, Goldstein DA. Retinoschisis in pars planitis. Ocul Immunol Inflamm. 2017;25(3):344–8.
Romero R, Peralta J, Sendagorta E, Abelairas J. Pars planitis in children: epidemiologic, clinical and therapeutic characteristics. J Pediatr Ophthalmol Strabismus. 2007;44:288–93.
Malinowski SM, Pulido JS, Folk JC. Long term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100:818–25.
Kim Y-K, Yoon W, Ahn JK, Park SP. Scleral buckling for rhegmatogenous retinal detachment associated with pars planitis. J Ophthalmol. 2016; Article ID 4538193, 5 p.
Smith RE, Godfrey WA, Kimura SJ. Chronic cyclitis. I. Course and visual prognosis. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:OP760–8.
Kalinina Ayuso V, ten Cate HA, van den Does P, Rothova A, de Boer JH. Young age as a risk factor for complicated course and visual outcome in intermediate uveitis in children. Br J Ophthalmol. 2011;95:646–51.
Zierhut M, Doycheva D, Biester S, Stübiger N, Kümmerle-Deschner J, Deuter C. Therapy of uveitis in children. Int Ophthalmol Clin. 2008;48:131–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 75080 kb)
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Faia, L.J. (2023). Pars Planitis in Children. In: Özdek, Ş., Berrocal, A., Spandau, U. (eds) Pediatric Vitreoretinal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-14506-3_53
Download citation
DOI: https://doi.org/10.1007/978-3-031-14506-3_53
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14505-6
Online ISBN: 978-3-031-14506-3
eBook Packages: MedicineMedicine (R0)